Chen, D., Rauh, M., Buchfelder, M., Eyupoglu, I. Y., & Savaskan, N. (2017). The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas. Oncotarget.
Chicago Style citaatChen, Daishi, Manfred Rauh, Michael Buchfelder, Ilker Y. Eyupoglu, en Nicolai Savaskan. "The Oxido-metabolic Driver ATF4 Enhances Temozolamide Chemo-resistance in Human Gliomas." Oncotarget 2017.
MLA citatieChen, Daishi, et al. "The Oxido-metabolic Driver ATF4 Enhances Temozolamide Chemo-resistance in Human Gliomas." Oncotarget 2017.
Let op: Deze citaties zijn niet altijd 100% accuraat.